Who We Serve: Clinical Area
Cardiovascular Devices
Cardiovascular devices work where failures have the most serious consequences, and their quality systems are inspected accordingly. Complaints, medical device reports and corrections tend to be numerous and closely read. We help cardiovascular manufacturers make sure each event was handled, decided and recorded the way an investigator expects.
Standards and Regulations to Know
- 21 CFR Part 814Premarket Approval
- 21 CFR Part 812Investigational Device Exemptions
- 21 CFR Part 803Medical Device Reporting
- 21 CFR Part 806Reports of Corrections and Removals
- ISO 14971Risk Management for Medical Devices
- ISO 10993-1Biological Evaluation Within a Risk Management Process
- ISO 14155Clinical Investigation of Medical Devices in Human Subjects
- 21 CFR Part 820 (QMSR)Quality Management System Regulation
Typical Regulatory Exposure
The category runs from guidewires and diagnostic catheters to heart valves, stents, ventricular assist devices and implantable pacemakers and defibrillators. Many of the higher-risk products are Class III and reach the market through PMA, often supported by clinical investigations under an IDE that bring bioresearch monitoring inspections with them.
Postmarket activity is heavy. Failures in this space can lead to death or serious injury, so medical device reporting decisions, complaint investigations and corrections and removals under 21 CFR Part 806 face close review. Investigators following a cluster of complaints will look at whether trending caught it, whether the CAPA addressed the cause, and whether a field action was considered.
Many cardiovascular devices depend on processes that are hard to verify: thin-wall extrusion, braiding, laser cutting, crimping and coatings. Drug-eluting products add a drug constituent that makes the device a combination product. Process validation, coating integrity and particulate control are recurring themes in audits of these products.
Where Audits Find Gaps
- 01
Reportability Decisions Without Reasoning
Complaints involving serious injury or malfunction were judged not reportable, but the file does not record the information considered or why the conclusion was reached.
- 02
Trending That Misses Clusters
Complaint trending runs on broad categories, so a rise in one failure mode on one product line is averaged away.
- 03
Unreported Corrections Without Records
A correction or removal was judged not reportable, but the record of the action and the justification for not reporting it was never created.
- 04
Coating and Particulate Evidence Thin
Coating integrity and particulate testing were done on design verification samples, with no ongoing monitoring tied to production lots or process changes.
- 05
Validation Sampling Misses Critical Features
Extrusion, laser cutting or crimping validations use sampling and acceptance criteria that do not reflect the critical dimensions of the current design.
Relevant Standards and Regulations
- 21 CFR Part 814Premarket Approval
- 21 CFR Part 812Investigational Device Exemptions
- 21 CFR Part 803Medical Device Reporting
- 21 CFR Part 806Reports of Corrections and Removals
- ISO 14971Risk Management for Medical Devices
- ISO 10993-1Biological Evaluation Within a Risk Management Process
- ISO 14155Clinical Investigation of Medical Devices in Human Subjects
- 21 CFR Part 820 (QMSR)Quality Management System Regulation
Relevant Services
CAPA System Remediation
Fixing a CAPA system auditors keep citing: the procedure, the records, root cause, effectiveness and backlog.
PMA Pre-Approval Inspection Preparation
Getting Class III manufacturers ready for the facility inspection that accompanies PMA review.
FDA Inspection Readiness (CP 7382.850)
FDA device inspection preparation built around Compliance Program 7382.850 and its risk-based approach.
BIMO (Clinical) Inspection Readiness
Readiness for FDA bioresearch monitoring inspections of device clinical studies: sponsors, CROs and sites.
Form 483 Response and Remediation
A structured, evidence-backed response to each Form 483 observation, and the remediation behind it.
Audits and Inspections You May Face
FDA PMA Pre-Approval Inspection
An FDA inspection tied to a PMA application that checks your quality system and its match to the submission.
FDA For-Cause Inspection
An FDA inspection prompted by specific information, such as complaints, MDRs or recalls, and focused on it.
FDA BIMO (Clinical Investigation) Inspection
FDA inspection of a clinical investigation's sponsor, monitors, investigators or IRB under 21 CFR Part 812.
FDA Baseline Surveillance Inspection
FDA's comprehensive surveillance inspection of your quality system under Compliance Program 7382.850.
Questions
What do investigators look at first in a complaint-heavy firm?
Inspections are risk-based and start from your risk management documentation, so investigators often move quickly to the complaints, MDRs and corrections tied to your highest-risk products. They will sample individual files and check that each decision has a recorded rationale.
How should we document a correction we decided not to report?
21 CFR Part 806 expects a record of corrections and removals that are not reported to FDA, including the justification for not reporting. Keep it with the related complaints and CAPA so an investigator can follow the decision from start to finish.
We have a drug-eluting product. Does that change the audit?
Yes. A drug-eluting device is generally regulated as a combination product, so the drug constituent brings its own manufacturing and quality expectations. Expect questions about how drug content, uniformity and release are controlled alongside the device processes.
Cardiovascular Devices
Get an Advisor's View of Your Quality System
Tell us about your devices and the audit or inspection ahead, and an advisor will scope an assessment for your kind of product. Please don't send confidential documents yet: secure upload is set up after onboarding.
